Sector: Pharmaceuticals & Biotechnology

Mid Cap

Aarti Pharmalabs Share Price

Aarti Pharmalabs Ltd.

₹687.60

-11.15(-1.60%)

Invest in AARTIPHARM with up to 2.50x margin.

Trade with MTF

23rd Feb 2026 | 3:28 PM

NSE : AARTIPHARM

Open Free Demat Account

Aarti Pharmalabs Performance

Price Movement

₹687.60

₹682.90

₹709.75

↘ Today's Low↗ Today's High

1 Year Performance

₹687.60

₹574.45

₹971.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹709.75

Low₹682.90

Open at₹700.10

Prev Close₹698.75

Volumes2.09 L

Avg Price₹692.48

Lower Circuit₹559.00

Upper Circuit₹838.50

Historical Performance

3M High₹817.90

3M Low₹672.70

1 Yr High₹971.00

1 Yr Low₹574.45

3 Yr High₹971.00

3 Yr Low₹269.00

5 Yr High₹971.00

5 Yr Low₹234.80

Aarti Pharmalabs Fundamentals

Market Cap

Above industry Median

6,227.30 Cr.

PE Ratio (TTM)

Above industry Median

29.10

Dividend Yield

Above industry Median

0.60

Net Profit TTM

14% decr over last year

213.72

Net Profit Growth

14% decr over last year

213.72

PEG Ratio

Negative PEG TTM

-2

ROE

10.9% incr over last year

13.68

Operating Revenue TTM

1,800.58

Operating Revenue Growth

12% decr over last year

Book Value

Above industry Median

MFI

MFI oversold

21.60

RSI

RSI is mid-range

35.67

EPS (TTM)

30.06

Debt to Equity

0.20

Face Value

Operating Profit Margin Qtr.

21.85

Operating Profit Qtr.

102.31

Net Profit Qtr.

47.96

Operating Revenue Qtr.

432.27

PB Ratio

Aarti Pharmalabs Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	425.25	417.29	375.31	529.62	470.95
Operating Expense	322.31	343.31	280.18	386.50	355.96
Operating Profit	102.94	73.98	95.13	143.13	114.99
Depreciation	28.62	24.77	22.76	20.83	21.04
Interest	12.58	10.66	6.79	6.29	9.70
Tax	14.74	10.77	15.95	24.66	22.66
Net Profit	43.84	30.93	51.22	88.85	73.52

AARTIPHARM Stock Recommendation by HDFC

View Call ↗

Research Type

Equity , Long Term

Buy Range

₹733 - ₹751

Target Price

₹868

Stop Loss

Target Date

14 Sep 26

Potential Returns

18.42 %

View Call ↗

Aarti Pharmalabs Technicals

Aarti Pharmalabs Ltd. EMA & SMA

₹687.60

-11.15 (-1.60%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹704.6

Day EMA10 ₹718.9

Day EMA12 ₹723.2

Day EMA20 ₹734.5

Day EMA26 ₹739.1

Day EMA50 ₹749.2

Day EMA100 ₹767.3

Day EMA200 ₹773.8

Aarti Pharmalabs Support and Resistance

Resistance

First Resistance₹703.47

Second Resistance₹720.03

Third Resistance₹730.32

Support

First Support₹676.62

Second Support₹666.33

Third Support₹649.77

Technical Indicators

Day RSI35.67

Day MFI21.60

Day ADX18.99

Day Commodity Channel Index-128.90

William-96.58

Day MACD-15.90

Day MACD Signal Line-8.44

Day ATR27.15

Day ROC125-20.43

Day ROC21-10.64

Aarti Pharmalabs Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	46.1	44.7	44.3	43.7	42.9	43.1
FII	7.4	8.6	7.4	7.3	8	7.7
DII	11.3	10.4	7.5	7.9	7	7.7
Public	35.2	36.3	40.8	41.1	42.1	41.5

Aarti Pharmalabs Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	1.11 L	1.97 L	56.28%
Week	65.17 K	1.26 L	51.59%
1 Month	1.01 L	2.12 L	47.52%
6 Month	1.24 L	2.55 L	48.46%

Aarti Pharmalabs SWOT Analysis

Strengths9

Weakness14

Opportunity2

Threats1

Benjamin Graham Value Screen

PEG lower than Industry PEG

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing Revenue every quarter for the past 2 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Aarti Pharmalabs Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
16 Feb, 2026	1.5	INTERIM	16 Feb, 2026	Equity Share
15 Sep, 2025	2.5	FINAL	15 Sep, 2025	Equity Share
14 Feb, 2025	2.5	INTERIM	14 Feb, 2025	Equity Share
31 Jul, 2024	1	FINAL	31 Jul, 2024	Equity Share
16 Feb, 2024	2	INTERIM	19 Feb, 2024	Equity Share

Aarti Pharmalabs Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	Rubicon Research Ltd.	Sai Life Science Ltd.	OneSource Specialty Pharma Ltd.	Sanofi Consumer Healthcare India Ltd.
Price (₹)	₹1,577	₹628.95	₹780	₹968	₹1,320	₹4,075
% Change	3.47%	-5.40%	-0.01%	2.83%	3.96%	0.75%
Revenue TTM (₹ Cr)	-	-	₹1,598.19	₹2,169.86	₹1,419.33	₹798.10
Net Profit TTM (₹ Cr)	-	-	₹206.20	₹332.94	₹20.10	₹217.90
PE TTM	-	-	62.20	61.50	754.90	43.10
1 Year Return	48.29	6.51	60.63	37.17	3.9	-12.48
ROCE	30.24	34.78	34.76	12.51	3.26	-

Similar Stocks

AKUMS

Akums Drugs & Pharmaceuticals Ltd.

₹ 474.00

-0.91%

BLUEJET

Blue Jet Healthcare Ltd

₹ 391.40

+9.99%

CONCORDBIO

Concord Biotech Ltd.

₹ 1103.00

+0.46%

SUPRIYA

Supriya Lifescience Ltd.

₹ 670.00

-1.17%

ACUTAAS

Acutaas Chemicals Ltd.

₹ 2138.50

+1.52%

ALIVUS

Alivus Life Sciences Ltd.

₹ 901.15

-1.08%

COHANCE

Cohance Lifesciences Ltd.

₹ 315.10

+3.18%

ERIS

Eris Lifesciences Ltd.

₹ 1358.00

+1.16%

SYNGENE

Syngene International Ltd.

₹ 448.60

+1.33%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 774.90

+1.55%

STAR

Strides Pharma Science Ltd.

₹ 872.90

+0.37%

GRANULES

Granules India Ltd.

₹ 598.00

-0.18%

FDC

FDC Ltd.

₹ 383.00

+3.82%

SHILPAMED

Shilpa Medicare Ltd.

₹ 329.00

+1.29%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 900.00

+3.15%

NATCOPHARM

Natco Pharma Ltd.

₹ 886.00

-0.64%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 1739.00

+2.77%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 13507.00

+6.88%

MARKSANS

Marksans Pharma Ltd.

₹ 179.32

+0.53%

SANOFI

Sanofi India Ltd.

₹ 4080.00

+1.34%

PGHL

Procter & Gamble Health Ltd.

₹ 5080.00

+1.21%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 674.90

-2.16%

FAQ's on AARTIPHARM

What is the current share price of Aarti Pharmalabs Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Aarti Pharmalabs Ltd. is ₹ 687.6 on the NSE and ₹ 690 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Aarti Pharmalabs Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Aarti Pharmalabs Ltd. is approximately ₹ 6227.3 Cr.

What are the PE and PB ratios for Aarti Pharmalabs Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Aarti Pharmalabs Ltd. is 29.1, and the Price-to-Book (PB) ratio is 3.

What is the 52-Week High and Low for Aarti Pharmalabs Ltd.?

Over the past 52 weeks, the highest price reached by Aarti Pharmalabs Ltd. shares was ₹ 971, and the lowest price was ₹ 574.45.

What is the current dividend yield for Aarti Pharmalabs Ltd.?

As of 6 June 2025, the dividend yield for Aarti Pharmalabs Ltd. is 0.6%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Aarti Pharmalabs Ltd.?

Significant shareholdings in Aarti Pharmalabs Ltd. typically include entities such as:

Promoter
Public
FII
Other Institutions
Mutual Funds

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Aarti Pharmalabs Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Aarti Pharmalabs Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

What is the latest dividend information for Aarti Pharmalabs Ltd.?

Aarti Pharmalabs Ltd. last declared a INTERIM dividend of ₹ 1.5 per share for the financial period ending 2026. The record date was set as 2026-02-16, and the payment was/is scheduled around 2026-02-16. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy